ICM
MMS icon

Invenomic Capital Management’s Maximus MMS Stock Holding History

Invenomic Capital Management’s Portfolio MMS Stock Details MMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
+34,026
New +$2.12M 0.11% 107

Other funds holding MMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Invenomic Capital Management's MMS Position: Q2 2026 in Review

Invenomic Capital Management opened a new position in Maximus (MMS) in Q2 2026: 34,026 shares worth $1.83M. The stake represents 0.11% of the portfolio and ranks #107 among its holdings.

349 funds tracked by Wall St. Rank hold MMS as of Q2 2026.

  • Invenomic Capital Management held 34,026 shares of Maximus worth $1.83M as of Q2 2026.
  • Maximus was a new Invenomic Capital Management position in Q2 2026.
  • Maximus made up 0.11% of Invenomic Capital Management's portfolio in Q2 2026, its #107 holding.
  • 349 funds tracked by Wall St. Rank held Maximus as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.